Dimension Therapeutics Inc logo

DMTX - Dimension Therapeutics Inc Share Price

$5.95 0.0  0.0%

Last Trade - 06/11/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £12.1m
Position in Universe th / 6630
Bullish
Bearish
Unlock DMTX Revenue
Momentum
Relative Strength (%)
1m -4.69%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
0.000 0.000 0.000 2.75 7.75 11.5 15.6 15.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2017,Dimension Therapeutics Inc revenues increased 70% to$12.5M. Net loss increased 19% to $42.7M. Revenues reflectan increase in demand for the Company's products andservices due to favorable market conditions. Higher netloss reflects Research and development - Balancing increaseof 30% to $43M (expense), General and administrative -Balancing. increase of 22% to $9.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DMTX Revenue Unlock DMTX Revenue

Net Income

DMTX Net Income Unlock DMTX Revenue

Normalised EPS

DMTX Normalised EPS Unlock DMTX Revenue

PE Ratio Range

DMTX PE Ratio Range Unlock DMTX Revenue

Dividend Yield Range

DMTX Dividend Yield Range Unlock DMTX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
DMTX EPS Forecasts Unlock DMTX Revenue
Profile Summary

Dimension Therapeutics, Inc. is a gene therapy company. The Company is focused on discovering and developing therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. It has programs for hemophilia B, hemophilia A, ornithine transcarbamylase (OTC) deficiency, and glycogen storage disease type Ia (GSDIa). The Company's gene therapy product candidates and programs are designed to provide a functional copy of an abnormal or missing gene using the advanced adeno-associated virus (AAV)-based vector delivery technology. DTX101 is the Company's lead gene therapy product candidate designed to deliver Factor IX (FIX), gene expression in patients with hemophilia B. DTX201 is its Factor VIII (FVIII) gene therapy program for the treatment of hemophilia A. DTX301 is its gene therapy product candidate designed for the treatment of patients with OTC deficiency. DTX401 is its gene therapy program for the treatment of patients with GSDIa.

Directors
Last Annual December 31st, 2016
Last Interim September 30th, 2017
Incorporated June 20, 2013
Public Since October 22, 2015
No. of Shareholders: n/a
No. of Employees: 74
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Select Market
Shares in Issue 25,371,591
Free Float (0.0%)
Eligible for
ISAs
SIPPs
DMTX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DMTX
Upcoming Events for DMTX
Frequently Asked Questions for Dimension Therapeutics Inc
What is the Dimension Therapeutics Inc share price?

As of 06/11/17, shares in Dimension Therapeutics Inc are trading at $5.95, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Dimension Therapeutics Inc share price performed this year?

Shares in Dimension Therapeutics Inc are currently trading at $5.95 and the price has moved by 30.77% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Dimension Therapeutics Inc price has moved by 11.84% over the past year.

What are the analyst and broker recommendations for Dimension Therapeutics Inc?

Of the analysts with advisory recommendations for Dimension Therapeutics Inc, there are there are currently 0 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Dimension Therapeutics Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Dimension Therapeutics Inc next release its financial results?

Dimension Therapeutics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-09-30
What is the Dimension Therapeutics Inc dividend yield?

Dimension Therapeutics Inc does not currently pay a dividend.

Does Dimension Therapeutics Inc pay a dividend?

Dimension Therapeutics Inc does not currently pay a dividend.

When does Dimension Therapeutics Inc next pay dividends?

Dimension Therapeutics Inc does not currently pay a dividend.

How do I buy Dimension Therapeutics Inc shares?

To buy shares in Dimension Therapeutics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Dimension Therapeutics Inc?

Shares in Dimension Therapeutics Inc are currently trading at $5.95, giving the company a market capitalisation of £n/a.

Where are Dimension Therapeutics Inc shares listed? Where are Dimension Therapeutics Inc shares listed?

Here are the trading details for Dimension Therapeutics Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: DMTX
What kind of share is Dimension Therapeutics Inc?

We were not able to load our ranking data for Dimension Therapeutics Inc

Is there a Dimension Therapeutics Inc share price forecast 2021?

We were not able to load any forecast data for Dimension Therapeutics Inc.

How can I tell whether the Dimension Therapeutics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dimension Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been 0.271k%. At the current price of $5.95, shares in Dimension Therapeutics Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Dimension Therapeutics Inc PE Ratio?

We were not able to find PE ratio data for Dimension Therapeutics Inc.

Who are the key directors of Dimension Therapeutics Inc?

We were unable to find the directors for Dimension Therapeutics Inc.

Who are the major shareholders of Dimension Therapeutics Inc?

Here are the top five shareholders of Dimension Therapeutics Inc based on the size of their shareholding:

Similar to DMTX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.